# A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol or Taxotere) Therapy.

> **NCT00063102** · PHASE2 · COMPLETED · sponsor: **Abbott** · enrollment: 40 (—)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** ABT-751

## Key facts

- **NCT ID:** NCT00063102
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-11
- **Primary completion:** —
- **Final completion:** 2004-08
- **Target enrollment:** 40 (—)
- **Last updated:** 2007-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00063102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00063102, "A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol or Taxotere) Therapy.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00063102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*